Day One - Western European Summer Time (WEST)
- Adam Griffiths - Portfolio Manager, LSX
- Alexander Zehnder - CEO, CureVac
- Laura Lane - Vice President Venture Science (Head of Europe), Eli Lilly & Co. Ltd.
- Matthew Edwards - Partner, Brown Rudnick
- Anta Gkelou - Partner, Sofinnova Partners
- Regina Hodits - Managing Director, Angelini Ventures
- Tim Haines - Executive Partner, Abingworth
- Maha Radhakrishnan - Executive Partner, Sofinnova Investments
- Amanda Gett - Partner, Kurma Partners
- Michael White - Head of Life Sciences, HSBC Innovation Bank, EMEA
- João Incio - General Partner, Biovance Capital
- Daniela Begolo - Managing Director, EQT Life Sciences
- Arvind Shandilya - Associate, Calculus Capital
- Kelly Provost - Partner, Head of Life Sciences Capital Markets, CFGI
- Thomas Thestrup - Senior Principal, Angelini Ventures
- Mukul Mohanty - Senior Partner, Truffle Capital
- Giovanni Rizzo - Partner Biotech Fund, Indaco Venture Partners
- David Jenkins - SVP, Research and External Innovation, Ipsen
- Gwilym Attwell - Principal, Fish & Richardson P.C.
- Chris Brown - Executive Director, Business Development Transaction, GSK
- Muhammad Mustaqim - Director, Transactions, Business Development Operations, AstraZeneca
- Carina Santos - Strategic Alliance Executive, Cancer Research Horizons
- Lisa Melton - Senior News Editor, Nature Biotechnology
- Katie Anastasi-Frankovics - Head of Innovation and Access, The Wellcome Trust
- Pietro Puglisi - Partner, Claris Ventures
- Florence Bosco - CEO, Quantum BioVenture Studio
- Joachim Keller - Principal, EU Emerging Biopharma, ZS
- Willem van Weperen - CEO, Pluvia Biotech
- Georg Meyer - SVP Head of International, Blueprint Medicines
- Nancy Hunter - Commercial Lead, Collabio Healthcare
- Joseph Dagher - SVP, Head of Europe, Cytokinetics
- Helen Tayton-Martin - Co-Founder and Former Chief Business and Strategy Officer, Adaptimmune
- Melanie Toyne-Sewell - Managing Director, Vigo Consulting
- Ragip M Ziyal - Head of Corporate Development, Tillotts Pharma
- Ingo Lehrke - CBO, Tubulis
- Mathias Vinther - Principal, Forbion
- Mary-Ann Chang - Investor Relations & Communications Advisor, Cohesion Bureau
- Vanela Bushi - Co-founder & GP, H Tree Capital
- Pierre-Louis Joffrin - Associate Partner, Syncona
- Marc Dechamps - CEO, Bioxodes
How to Take Your Company Public: Insights and Strategies for Biotech Success
- When is the right time for a biotech to go public, and what are the key steps to prepare?
- How can companies navigate complex financial and regulatory environments across global markets?
- What do investors look for, and how can biotechs build trust and confidence with them?
- What are the most common pitfalls during the IPO process, and how can they be avoided?
- Linda McGoldrick Ph.D - Board Director, Alvotech
- Giles Hamilton - Operating Partner, New Growth Advisors
- Edoardo Negroni - Co-Founder & Managing Partner, AurorA-TT
- Herve de Kergrohen - Venture Partner, Alpha Blue Ocean
- Edouard Guillet - MD, IPF Partners
- David Danovitch - Partner, Sullivan & Worcester
- Chuck Bennett - CEO, CORE IR Public & Investor Relations
- Christopher Church - Head of Technology Search and Evaluation, Biopharmaceuticals R&D, AstraZeneca
- Deborah Sterling - Director, Sterne Kessler
- Bernd Muehlenweg - SVP, Global BD, Evotec
- Anja Bitterwolf - Director, Global Business Development and Licensing, Debiopharm International SA
- Konstantin Petropoulos - CEO, Secarna Pharmaceuticals
- Olga Krylova - Head of S&E, Europe, Global Business Development & Innovation, Otsuka
- Rowan Gardner - CBIO, Precision Life
- Jenny Laird - VP, Search & Evaluation Neuroscience, Eli Lilly and Company
- Sahil Kirpekar - Founder, Lumina Life Sciences
- Colleen Acosta - CEO-Founder & CEO, Freya Biosciences
- Paul Holmes - EU Commercialisation Lead, Syneos Health
- Sana Alajmovic - Co-Founder & CEO, Sigrid Therapeutics
- Jenny Barnett - CEO, Monument Therapeutics
- Maria Dahl - COO and Head of Innovent Biologics (Europe), Innovent Biologics
- Sohail Zaidi - CEO, Ananda Scientific
- Paul Beresford - SVP New Product Planning & Business Transformation, iOnctura
- James Wang - Head of BD, Adcendo
Creating a successful biotech company is about more than breakthrough science—it's about building an organization where people and ideas can thrive. In this panel, experienced biotech leaders will discuss how to shape leadership teams and cultural frameworks that drive innovation, resilience, and long-term success. They’ll share hard-earned lessons, practical strategies, and actionable insights for cultivating a dynamic and purpose-driven workplace.
The Role of Leadership in Shaping Culture: How strong, authentic leadership creates a foundation for positive and productive company culture
Meeting Evolving Employee Expectations: What today’s biotech talent values in organizational culture—and how to stay aligned
Culture as a Catalyst: Practical steps to foster innovation, collaboration, and a growth mindset across all levels of the company
- Renee Aguiar-Lucander - Chief Executive Officer, Calliditas Therapeutics
- Christer Ahlberg - CEO, Cinclus Pharma
- Quin Wills - Founder & CSO, Ochre Bio
- Guy Martin - News Editor, The Pharma Letter
- Wanda Rutledge-Gordon - Chief Alliance Officer, Eli Lilly
- Melanie Howard - Partner, Latham & Watkins
- Chris Sheldon - Senior Vice President, Head of Business Development, GSK
- Juergen Eckhardt - EVP, Head of Leaps by Bayer, Head of Pharma BD&L, Bayer